Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

LBBAP limits hospital readmissions after TAVR
Left bundle branch area pacing is associated with better long-term outcomes than traditional right ventricular pacing when patients require PPMI after TAVR, according to new research in Heart Rhythm.
FDA approves Boston Scientific leads for left bundle branch area pacing
Boston Scientific's INGEVITY+ pacing leads were originally approved by the FDA back in 2019. They can now be used for LBBAP, a new alternative to biventricular pacing.
JACC editor excited by progress during a 'very important moment' for cardiology
Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.
FDA approves Biotronik lead, catheter for left bundle branch area pacing
LBBAP is a relatively new alternative to biventricular pacing. The FDA's decision was based largely on data from the BIO-CONDUCT clinical trial.
Surgeons make history, perform world’s first fully robotic heart transplant
The procedure, which lasted roughly two and half hours, was performed on a 16-year-old patient with end-stage heart failure.

KCCQ-12 scores a valuable asset for managing patients with acute HF

The scores can help predict a patient's short- and long-term risk of adverse outcomes.

December 7, 2021

DOACs outperform VKAs among cardiac amyloidosis patients with HF, AFib

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin.

December 2, 2021

SGLT2 inhibitors lower risk of HFpEF, new meta-analysis confirms

Patients taking SGLT2 inhibitors were 22% less likely to die from heart-related causes.

December 1, 2021

Cardiac rehabilitation benefits heart failure patients—but for how long?

The study tracked 2,876 patients hospitalized for acute HF or deteriorating chronic HF.

November 29, 2021

In-hospital mortality more common among COVID-19 patients with heart failure

The authors also noted that cardiac complications such as myocarditis, MI and new-onset heart failure were rare during hospitalization for COVID-19.

November 23, 2021

Aspirin use may increase your risk of heart failure

Doctors may not want to prescribe aspirin to patients presenting with obesity, high blood pressure, diabetes or a number of other risk factors.

November 23, 2021

What we know about COVID-19 and cardiogenic shock

The full analysis was published in Circulation: Heart Failure.

November 22, 2021

Is depression a warning sign for heart failure?

The study, published in the Journal of the American Heart Association, examined how certain symptoms related to depression might be associated with a person's risk of HFpEF and HFrEF.

November 22, 2021

Heart Failure

LBBAP limits hospital readmissions after TAVR

FDA approves Boston Scientific leads for left bundle branch area pacing

JACC editor excited by progress during a 'very important moment' for cardiology

FDA approves Biotronik lead, catheter for left bundle branch area pacing

Surgeons make history, perform world’s first fully robotic heart transplant